Jump to content

Talk:Efonidipine

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by Cewbot (talk | contribs) at 20:08, 17 January 2024 (Maintain {{WPBS}} and vital articles: 1 WikiProject template. Create {{WPBS}}. Keep majority rating "C" in {{WPBS}}. Remove 1 same rating as {{WPBS}} in {{WikiProject Pharmacology}}.). The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

Pharmaceutical company marketing

[edit]

In the section "Efonidipine-The Best in Class", the author appears to rely on cherry-picking of primary sources to make claims that are not made in the sources themselves, and not verified by secondary medical sources. I think this is pharmaceutical company marketing. The rest of the article should get a thorough peer review as well. — Preceding unsigned comment added by 108.16.253.48 (talk) 14:12, 30 September 2018 (UTC)[reply]